Quick links

Amgen to Build New $300M Facility After Tax Changes

Amgen plans to invest $3.5 billion in capital expenditures over the next five years. About 75 percent will be in the U.S., up from about 50 percent in the preceding years. Part of the investment is $300 million for a new drug manufacturing site in the U.S. It is expected to add 220 jobs to the local economy and employ up to 300 full-time employees. The plan is expected to manufacture products for both domestic and foreign markets, and have the capacity to manufacture complex biologic therapeutics. Source: Biospace 2/2/2018